In addition, we showed that positive expression of SIRT1 protein was significantly associated with unfavorable prognosis, indicating that SIRT1 protein may be useful in predicting prognosis and could represent a novel therapeutic target for ESCC patients. This evidence concerns the gene SIRT1 and esophageal squamous cell carcinoma.